As of 2026-10-09, the Relative Valuation of Fulcrum Therapeutics Inc (FULC) is (10.86) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.75 USD, the upside of Fulcrum Therapeutics Inc based on Relative Valuation is -389.7%.
The range of the Relative Valuation is (7.09) - (14.51) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.3x - 19.6x | 12.4x |
| Forward P/E multiples | 8.3x - 16.9x | 12.9x |
| Fair Price | (7.09) - (14.51) | (10.86) |
| Upside | -289.2% - -487.1% | -389.7% |
| Date | P/E |
| 2026-10-06 | -4.30 |
| 2026-10-05 | -4.32 |
| 2026-10-02 | -4.30 |
| 2026-10-01 | -4.28 |
| 2026-09-30 | -4.31 |
| 2026-09-29 | -4.31 |
| 2026-09-28 | -4.33 |
| 2026-09-25 | -4.35 |
| 2026-09-24 | -4.41 |
| 2026-09-23 | -4.44 |
| 2026-09-22 | -4.47 |
| 2026-09-21 | -4.42 |
| 2026-09-18 | -4.38 |
| 2026-09-17 | -4.39 |
| 2026-09-16 | -4.41 |
| 2026-09-15 | -4.40 |
| 2026-09-14 | -4.41 |
| 2026-09-11 | -4.42 |
| 2026-09-10 | -4.42 |
| 2026-09-09 | -4.47 |
| 2026-09-08 | -4.45 |
| 2026-09-04 | -4.48 |
| 2026-09-03 | -4.47 |
| 2026-09-02 | -4.48 |
| 2026-09-01 | -4.51 |
| 2026-08-31 | -4.53 |
| 2026-08-28 | -4.48 |
| 2026-08-27 | -4.48 |
| 2026-08-26 | -4.49 |
| 2026-08-25 | -4.49 |
| 2026-08-24 | -4.47 |
| 2026-08-21 | -4.46 |
| 2026-08-20 | -4.48 |
| 2026-08-19 | -4.55 |
| 2026-08-18 | -4.51 |
| 2026-08-17 | -4.47 |
| 2026-08-14 | -4.35 |
| 2026-08-13 | -4.32 |
| 2026-08-12 | -4.33 |
| 2026-08-11 | -4.30 |
| 2026-08-10 | -4.37 |
| 2026-08-07 | -4.53 |
| 2026-08-06 | -4.39 |
| 2026-08-05 | -4.39 |
| 2026-08-04 | -4.42 |
| 2026-08-03 | -4.32 |
| 2026-07-31 | -4.17 |
| 2026-07-30 | -4.33 |
| 2026-07-29 | -4.21 |
| 2026-07-28 | -4.33 |